Anastasia Lesogor

Effect of Aliskiren on Postdischarge Mortality and Heart Failure Readmissions Among Patients Hospitalized for Heart Failure

Mihai Gheorghiade, Michael Böhm, Stephen J. Greene et al. · JAMA · 2013 · 324 citations · Full text

Long-term efficacy and safety of inclisiran in patients with high cardiovascular risk and elevated LDL cholesterol (ORION-3): results from the 4-year open-label extension of the ORION-1 trial

Kausik K. Ray, Roel P T Troquay, Frank L.J. Visseren et al. · The Lancet Diabetes & Endocrinology · 2023 · 282 citations · Full text

Lipoprotein(a) levels in a global population with established atherosclerotic cardiovascular disease

Steven E. Nissen, Kathy Wolski, Leslie Cho et al. · Open Heart · 2022 · 114 citations · Full text

Efficacy, Safety, and Tolerability of Inclisiran in Patients With Homozygous Familial Hypercholesterolemia: Results From the ORION-5 Randomized Clinical Trial

Frederick J. Raal, Ronen Durst, Ran Bi et al. · Circulation · 2023 · 69 citations · Full text

Safety and Tolerability of Inclisiran for Treatment of Hypercholesterolemia in 7 Clinical Trials

R. Scott Wright, Wolfgang Köenig, Ulf Landmesser et al. · Journal of the American College of Cardiology · 2023 · 65 citations · Full text